Cryopreserved anti-CD22 and bispecific anti-CD19/22 CAR-T cells are as effective as freshly infused cells

被引：0
|
作者：
Dreyzin, Alexandra [1 ]
Panch, Sandhya [2 ]
Shalabi, Haneen [3 ]
Yates, Bonnie [3 ]
Shah, Nirali [3 ]
Stroncek, David [2 ]
机构：
[1] Childrens Natl Hosp, Ctr Canc & Blood Disorders, Washington, DC USA
[2] NIH, Dept Transfus Med & Cellular Engn, Ctr Cellular Engn, Clin Ctr, Bldg 10, Bethesda, MD 20892 USA
[3] NCI, Pediat Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
来源：
PEDIATRIC BLOOD & CANCER | 2022年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
13
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Anti-CD19 CAR T Cells in Refractory Immune Thrombocytopenia of SLE
    Li, Mengtao
    Zhang, Yan
    Jiang, Nan
    Ning, Chun
    Wang, Qian
    Xu, Dong
    Wang, Ziqian
    Lv, Lulu
    Zhou, Daobin
    Zeng, Xiaofeng
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (04): : 376 - 378
  • [42] Anti-CD19/CD22 Dual CAR-T Therapy for Refractory and Relapsed B-Cell Acute Lymphoblastic Leukemia
    Yang, Junfang
    Jiang, Pengfei
    Zhang, Xian
    Zhu, Xiaobin
    Dong, Qi
    He, Jiaping
    Lin, Nanjing
    Wang, Zhenguang
    Cai, Songbai
    Ye, Xun
    Su, Yunchao
    Li, Wenqian
    Li, Jingjing
    Yu, Ziyao
    He, Jiujiang
    Xu, Li
    Song, Dan
    Cao, Wei
    Lu, Peihua
    BLOOD, 2019, 134
  • [43] Anti-CD19 CAR-T cells show pronounced effect on PC3M-CD19 tumor spheres
    Rakhmatulllina, A.
    Valiullina, A.
    Petukhov, A.
    Zolotykh, M.
    Bulatov, E.
    Miftakhova, R.
    Rizvanov, A.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2020, 50 : 83 - 83
  • [44] CAR-T ENGAGER PROTEINS OPTIMIZE ANTI-CD19 CAR-T CELL THERAPIES FOR LYMPHOMA
    Rennert, Paul
    Su, Lihe
    Wu, Lan
    Lobb, Roy
    Ambrose, Christine
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A187 - A187
  • [45] CAR-T Engager proteins optimize anti-CD19 CAR-T cell therapies for lymphoma
    Su, Lihe
    Wu, Lan
    Lobb, Roy R.
    Rennert, Paul D.
    Ambrose, Christine
    ONCOIMMUNOLOGY, 2022, 11 (01):
  • [46] Sequential Infusion of Anti-CD22 and Anti-CD19 Chimeric Antigen Receptor T Cells for Adult Patients with Refractory/Relapsed B-Cell Acute Lymphoblastic Leukemia
    Huang, Liang
    Wang, Na
    Li, Chunrui
    Cao, Yang
    Xiao, Yi
    Xiao, Min
    Zhang, Yicheng
    Zhang, Tongcun
    Zhou, Jianfeng
    BLOOD, 2017, 130
  • [47] Anti-CD19 CAR T cells potently redirected to kill solid tumor cells
    Ambrose, Christine
    Su, Lihe
    Wu, Lan
    Dufort, Fay J.
    Sanford, Thomas
    Birt, Alyssa
    Hackel, Benjamin J.
    Hombach, Andreas
    Abken, Hinrich
    Lobb, Roy R.
    Rennert, Paul D.
    PLOS ONE, 2021, 16 (03):
  • [48] Fine-Tuned Anti-CD19 CAR-T Cells to Improve Anti-Tumor Activity By Smash Platform
    Choi, Byungsan
    Kang, Minsoo
    Woo, Janghee
    BLOOD, 2024, 144 : 4990 - 4990
  • [49] Fine-Tuned Anti-CD19 CAR-T Cells to Improve Anti-Tumor Activity By Smash Platform
    Choi, Byungsan
    Kang, Minsoo
    Woo, Janghee
    BLOOD, 2024, 144 : 4990 - 4990
  • [50] GENERATION AND OPTIMIZATION OF ANTI-CD19 CAR-T CELL FOR LEUKEMIA IMMUNOTHERAPY
    Silva, L. R. B.
    Abdo, L.
    Mazzi, M.
    Aragao, E.
    Hadju, K.
    Andrade, C.
    Bonamino, M. H.
    CYTOTHERAPY, 2022, 24 (10) : S27 - S28
12345